These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19555137)

  • 1. Warfarin potentiation: a review of the "FAB-4" significant drug interactions.
    Thi L; Shaw D; Bird J
    Consult Pharm; 2009 Mar; 24(3):227-30. PubMed ID: 19555137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy.
    Daniels LM; Barreto JN; Kuth JC; Anderson JR; Zhang B; Majka AJ; Morgenthaler TI; Tosh PK
    Am J Health Syst Pharm; 2015 Jul; 72(14):1195-203. PubMed ID: 26150569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?
    Teruel RS; Thue G; Fylkesnes SI; Sandberg S; Kristoffersen AH
    Scand J Prim Health Care; 2017 Sep; 35(3):299-306. PubMed ID: 28776437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing warfarin medication interactions: an interrupted time series evaluation.
    Feldstein AC; Smith DH; Perrin N; Yang X; Simon SR; Krall M; Sittig DF; Ditmer D; Platt R; Soumerai SB
    Arch Intern Med; 2006 May; 166(9):1009-15. PubMed ID: 16682575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between fenofibrate and warfarin.
    Ascah KJ; Rock GA; Wells PS
    Ann Pharmacother; 1998; 32(7-8):765-8. PubMed ID: 9681093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risks of warfarin use in the elderly.
    Bereznicki LR; Peterson GM; Jackson SL; Jeffrey EC
    Expert Opin Drug Saf; 2006 May; 5(3):417-31. PubMed ID: 16610970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.
    Hansen PW; Clemmensen L; Sehested TS; Fosbøl EL; Torp-Pedersen C; Køber L; Gislason GH; Andersson C
    Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):621-628. PubMed ID: 28263937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin and celecoxib interaction.
    Mersfelder TL; Stewart LR
    Ann Pharmacother; 2000 Mar; 34(3):325-7. PubMed ID: 10917378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulants. Pharmacologic issues for use in the elderly.
    Hylek EM
    Clin Geriatr Med; 2001 Feb; 17(1):1-13. PubMed ID: 11270124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noscapine and warfarin--a potentially dangerous interaction].
    Myhr K
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540. PubMed ID: 19282895
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between warfarin and oral terbinafine. Systematic review of interaction profile of warfarin is needed.
    Clarke MF; Boardman HS
    BMJ; 1998 Jul; 317(7152):205-6. PubMed ID: 9705640
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
    Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.
    Powers A; Loesch EB; Weiland A; Fioravanti N; Lucius D
    J Thromb Thrombolysis; 2017 Jul; 44(1):88-93. PubMed ID: 28417267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
    Hasan SA
    Cornea; 2007 Jul; 26(6):742-3. PubMed ID: 17592328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.
    Woeber KA; Warner I
    West J Med; 1999 Jan; 170(1):49-51. PubMed ID: 9926737
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated International Normalized Ratio values in a patient receiving warfarin and ceftaroline.
    Farhat NM; Hutchinson LS; Peters M
    Am J Health Syst Pharm; 2016 Jan; 73(2):56-9. PubMed ID: 26721534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions between warfarin and psychotropics: updated review of the literature.
    Nadkarni A; Oldham MA; Howard M; Berenbaum I
    Pharmacotherapy; 2012 Oct; 32(10):932-42. PubMed ID: 23033232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.